Iodine revisited

International Wound Journal

Volumn 4, Issue 2, 2007, Pages 124-137

  Cooper, Rose A ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Antimicrobial activity; Antiseptic; Cytotoxicity; Iodine; Resistance

Indexed keywords

IODINE; POVIDONE IODINE;

ANTIMICROBIAL ACTIVITY; BURN; CLINICAL STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND CARE;

EID: 34547126431     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2007.00314.x     Document Type: Review

References (103)

1. Gottardi W. Chapter 8: iodine and iodine compounds. In : Block SS, editor. Disinfection, sterilization and preservation, 3rd edn. Philadelphia : Lea & Febiger, 1983 : 183 96.
2. Gottardi W. The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine. J Hosp Infect 1985 6 (Suppl 1 11.
3. Gottardi W. Iodine and disinfection: theoretical study on mode of action, efficiency, stability, and analytical aspects in the aqueous system. Arch Pharm 1999 332 : 151 7.
4. Hugo WB. A brief history of heat and chemical preservation and disinfection. J Appl Bacteriol 1991 71 : 9 18.
5. Allawala NA, Riegelman S. The properties of iodine in solutions of surface active agents. J Am Pharm Assoc 1953 42 : 396 401.
6. Russell AD. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Bacteriol 2002 92 (Symp Suppl 121S 135S.
7. British Pharmacopoeia. Povidone iodine. p 1636 volume II. London : The Stationery Office, 2005.
8. Saggers BA, Stewart GT. Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity. J Hyg 1964 62 : 509 19.
9. Mårtenson L. Cadexomer iodine - an introduction. In : Iodine and wound physiology. Cambridge : Information transfer Ltd, 1995 : 1.1 1.2.
10. Duan Y, Dinehart K, Hickey J, Panicucci R, Kessler J, Gottardi W. Properties of an enzyme-based low-level iodine disinfectant. J Hosp Infect 1999 43 : 219 29.
11. Thorn RMS, Greenman J, Austin A. An in vitro study of antimicrobial activity and efficacy of iodine generating hydrogel dressings. J Wound Care 2006 15 : 305 10.
12. Vogt PM, Reimer K, Hauser J, Rosenbach O, Steinau HU, Bosse B, Muller S, Schmidt T, Fleischer W. PVP-iodine in hydrosomes and hydrogel-A novel concept in wound therapy leads to enhanced epithelialisation and reduced loss of skin grafts. Burns 2006 32 : 698 705.
13. Nakao H, Yamazaki M, Tsuboi R, Ogawa, H. Mixture of sugar and povidone-iodine stimulates wound healing by activating keratinocytes and fibroblast functions. Arch Dermatol Res 2006 298 : 175 82.
14. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986 151 : 400 6.
15. Lacey RW, Cato A. Action of povidone-iodine against methicillin-sensitive and resistant cultures of Staphylococcus aureus. Postgrad Med J 1993 69 (Suppl S78 83.
16. Yasuda T, Yoshimura S, Katsuno Y, Ito M, Takada H, Takahashi M, Yahazaki F, Iriyama J, Ishigo S, Asano Y. Comparison of bactericidal activities of various disinfectants against methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Postgrad Med J 1993 69 (Suppl S66 9.
17. Kunisada T, Yamada K, Oda S, Hara O. Investigation into the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 1997 195 (Suppl 14 8.
18. Okhiria O, Cooper R. Biofilms, wound infection and the issue of control. Wounds 2006 2 : 48 57.
19. Moore SL, Payne DN. Chapter 2: types of antimicrobial agents. In : Fraise AP, Lambert PA, Maillard J-Y, editors. Russell, Hugo & Ayliffe's principles and practice of disinfection, preservation & sterilization, 4th edn. Oxford : Blackwell Publishing, 2004 : 8 97.
20. Schreier H, Erdos G, Reimer K, Konig B, Konig W, Fleischer W. Molecular effects of povidone-iodine on relevant micro-organisms: an electron-microscopic and biochemical study. Dermatology 1997 195 (Suppl 111 6.
21. Pitten F-A, Werner H-P, Kramer A. A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003 55 : 108 15.
22. Mycock G. Methicillin/antiseptic-resistant Staphylococcus aureus. Lancet 1985 2 : 949 50.
23. McLure AR, Gordon J. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus. J Hosp Infect 1992 21 : 291 9.
24. Houang E, Gilmore OJA, Reid C, Shaw EJ. Absence of bacterial resistance to povidone iodine. J Clin Pathol 1976 29 : 752 5.
25. Traoré O, Fayard SF, Laveran H. An in-vitro evaluation of the activity of povidone-iodine against nosocomial bacterial strains. J Hosp Infect 1996 34 : 217 22.
26. Giacometti A, Cirioni O, Greganti G, Fineo A, Ghiselli R, Del Prete MS, Mocchegiani F, Fileni B, Caselli F, Petrelli E, Saba V, Scalise G. Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. Eur J Clin Microbiol Infect Dis 2002 21 : 553 6.
27. Klossner BL, Widmer H-R, Frey F. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology 1997 195 (Suppl 10 3.
28. Lawrence JC. The use of iodine as an antiseptic agent. J Wound Care 1998 7 : 421 5.
29. Woeber KA. Iodine and thyroid disease. Med Clin North Am 1991 75 : 169 78.
30. Richardson ML, Gangolli, S. Iodine. In : Richardson ML, Gangolli S, editors. The dictionary of substances and their effects. Vol 5. Cambridge : The Royal Society of Chemistry, 1994 : 47.
31. Weeke J. Chapter 41: thyroid and anti-thyroid drugs. In : Dukes MNG, Aronson JK, editors. Meyler's side effects of drugs, 14th edn. Amsterdam : Elsevier Science BV, 2000 1492 1493.
32. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes 2002 110 : 408 15.
33. Gottardi W. The uptake and release of molecular iodine by the skin: chemical and bactericidal evidence of residual effects caused by povidone-iodine preparations. J Hosp Infect 1995 29 : 9 18.
34. Van den Broek PJ, Buys LFM, Van Furth R. Interaction of povidone-iodine compounds, phagocytic cells, and micro-organisms. Antimicrob Agents Chemother 1982 22 : 593 7.
35. Balin AK, Pratt L. Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol Surg 2002 28 : 210 4.
36. Lineaweaver W, Howard R, Soucy D, McMorris S, Freeman J, Crain C, Robertson J, Rumley T. Topical antimicrobial toxicity. Arch Surg 1985 120 : 267 70.
37. Cooper ML, Laxer JA, Hansborough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 1991 31 : 775 84.
38. Wilson JR, Mills JG, Prather ID, Dimitrijevich SD. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005 18 : 373 8.
39. Hansborough JF, Zapata-Sirvent RI, Cooper ML. Effects of topical antimicrobial agents on human neutrophil respiratory burst. Arch Surg 1991 126 : 603 8.
40. Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V. Slow release iodine preparation and wound healing: in vitro effects with lack of in vitro toxicity in human chronic wounds. Br J Dermatol 2002 146 : 365 74.
41. Moore K, Thomas A, Harding KG. Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide. Int J Biochem Cell Biol 1997 29 : 163 71.
42. Schmidt RJ, Kirby AJ, Chung LY. Cadexomer iodine formulations may modulate the redox environment of wounds. In : Iodine and wound physiology. Cambridge : Information transfer Ltd, 1995 : 6.1 6.26.
43. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979 76 : 1274 8.
44. Cochrane CA, Shearwood C, Walker M, Bowler P, Knottenbelt DC. The application of a fibroblast gel contraction model to assess the cytotoxicity of topical antimicrobial agents. Wounds 2003 15 : 265 71.
45. Edlich RF, Custer J, Madden J, Dajani AS, Rogers W, Wangensteen OH. Studies in management of the contaminated wound. Am J Surg 1969 118 : 21 30.
46. Geronemus RG, Mertz PM, Eaglstein, WH. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 1979 115 : 1311 4.
47. Brennan SS, Leaper DJ. The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 1985 72 : 780 2.
48. Custer J, Edlich RF, Prusak M, Madden J, Panek P, Wangensteen OH. Studies in the management of the contaminated wound. Am J Surg 1971 121 : 572 5.
49. Iwasawa A, Nakamura Y. Cytotoxic effect and influence of povidone-iodine on wounds in guinea pig. J Jpn Assoc Infect Dis 2003 77 : 948 56.
50. Mertz PM, Oliveira-Gandia MF, Davis SC. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 1999 25 : 89 93.
51. Lamme EN, Gustafsson TO, Middlekoop E. Cadexomer-iodine ointment shows stimulation of epidermal regeneration in experimental full-thickness wounds. Arch Dermatol Res 1998 290 : 18 24.
52. Pietsch J, Meakins JL. Complications of povidone-iodine absorption in topically treated burns patients. Lancet 1976 1 : 280 2.
53. D'Auria J, Lipson S, Garfield JM. Fatal iodine toxicity following debridement of a hip wound: case report. J Trauma 1990 30 : 353 5.
54. Campistol JM, Abad C, Nogue S, Bertran A. Acute renal failure in a patient treated by continuous povidone-iodine mediastral irrigation. J Cardiovasc Surg (Torino) 1988 28 : 410 2.
55. Zec N, Donovan JW, Aufiero TX, Kincaid RL, Demers LM. Seizures in a patient treated with continuous povidone-iodine mediastral irrigation. N Engl J Med 1992 326 : 1784.
56. Lavelle KJ, Doedens DJ, Kleit SA, Forney RB. Iodine absorption in burns patients treated topically with povidone iodine. Clin Pharmacol Ther 1975 17 : 355 62.
57. Aronoff GR, Freidman SJ, Doedens DJ, Lavelle KJ. Increased serum iodide concentration from iodine absorption through wounds treated topically with povidone-iodine. Am J Med Sci 1980 279 : 173 6.
58. Nobukuni K, Hayakawa N, Namba R, Ihara Y, Sato K, Takada H, Hayabara T, Kawahara S. The influence of long-term treatment with povidone-iodine on thyroid function. Dermatology 1997 195 (Suppl 60 72.
59. Zellner PR, Bugyi S. Povidone-iodine in the treatment of burns patients. J Hosp Infect 1985 6 (Suppl 139 46.
60. Balogh D, Bauer M, Riccabona G. The influence of povidone-iodine treatment on thyroid hormones in severe burns. J Hosp Infect 1985 6 (Suppl 147 53.
61. Kovacikova L, Kunovsky P, Skrak P, Hraska V, Kostalova L, Tomeckova E. Thyroid hormone metabolism in pediatric cardiac patients treated by continuous povidone-iodine irrigation for deep sternal wound infection. Eur J Cardiothorac Surg 2002 21 : 1037 41.
62. Hunt JL, Sato R, Heck EL, Baxter CR. A critical evaluation of povidone-iodine absorption in thermally injured patients. J Trauma 1990 20 : 127 9.
63. Steen M. Review of the use of povidone-iodine (PVP-I) in the treatment of burns. Postgrad Med J 1993 69 (Suppl S84 92.
64. Machet L, Couhé C, Perrinaud A, Hoarau C, Lorette G, Vaillant L. A high prevalence of sensitisation still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta analysis. Br J Dermatol 2004 150 : 929 35.
65. Juhász I. Experiences with the use of povidone-iodine-containing local therapeutics in dermatological surgery and in the treatment of burns: testing for allergic sensitisation in post-surgery patients. Dermatology 2002 204 (Suppl 52 8.
66. Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Derm 2005 52 : 9 10.
67. Neidner R. Cytotoxicity and sensitisation of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997 195 (Suppl 89 92.
68. Dissemond J, Lehnen M, Körber A. Contact allergy in patients with chronic leg ulcers. Z Wundheil 2006 11 : 20 4.
69. Lyman IR, Tenery JH, Basson RP. Correlation between decrease in bacterial load and rate of wound healing. Surg Gynecol Obstet 1970 130 : 616 21.
70. Hendley JO, Ashe KM. Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin. Antimicrob Agents Chemother 1991 35 : 627 31.
71. Gallard RB, Saunders JH, Mosely JG, Darrell JH. Prevention of wound infection in abdominal operations by preoperative antibiotics or povidone-iodine. Lancet 1977 2 : 1045.
72. Viljanto J. Disinfection of surgical wounds without inhibition of wound healing. Arch Surg 1980 115 : 253 6.
73. Sindelar WF, Mason GR. Intraperitoneal irrigation with povidone-iodine solution for the prevention of intra-abdominal abscesses in the bacterially contaminated abdomen. Surg Gynecol Obstet 1979 148 : 409 11.
74. Gray JG, Lee MJ. The effect of topical povidone iodine on wound infection following gastrointestinal surgery. Br J Surg 1981 68 : 310 3.
75. Walsh JA, Watts JM, McDonald PJ, Finlay-Jones JJ. The effect of topical povidone-iodine on the incidence of infection in surgical wounds. Br J Surg 1981 68 : 185 9.
76. Gravett A, Sterner S, Clinton JE, Ruiz E. A trial of povidone-iodine in the treatment of infection in sutured lacerations. Ann Emerg Med 1987 16 : 167 71.
77. Lammers RL, Fourré M, Callaham ML, Boone T. Effect of povidone-iodine and saline soaking on bacterial counts in acute, traumatic, contaminated wounds. Ann Emerg Med 1990 19 : 709 14.
78. Marshall C, Queen J, Manjooran J. Honey vs povidone iodine following toenail surgery. Wounds 2005 1 : 10 8.
79. Edwards PG, Lipp A, Holmes A. Preoperative skin antiseptics preventing surgical wound infection after clean surgery. Cochrane Database Syst Rev 2004 (3) CD003949.
80. Kucan JO, Robson MC, Heggers JP, Ko F. Comparison of silver sulfadiazine, povidone-iodine and physiological saline in the treatment of chronic pressure ulcers. J Am Geriatr Soc 1981 29 : 232 5.
81. Knutson RA, Merbitz LA, Creekmore MA, Snipes HG. Use of sugar and povidone-iodine to enhance wound healing: five year's experience. South Med J 1981 74 : 1329 35.
82. Skog E, Arnesjo B, Troëng T, Gjoress JE, Bergljung L, Gundersen J, Hallbook T, Hessman Y, Hillstrom L, Mãnsson T, Eilard U, Ekloff B, Plate G, Norgren L. A randomised trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic leg ulcers. Br J Dermatol 1983 109 : 77 83.
83. Ormiston MC, Seymour MTJ, Venn GE, Cohen RI, Fox JA. Controlled trial of Iodosorb in chronic venous leg ulcers. Br Med J 1985 291 : 308 10.
84. Hansson C. The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Cadexomer Iodine Study Group. Int J Dermatol 1998 37 : 390 6.
85. Piérard-Franchimont C, Paquet P, Arrese JE, Piérard GE. Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology 1997 194 : 383 7.
86. Fumal I, Braham C, Paquet P, Piérard-Franchimont C, Piérard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology 2002 204 (Suppl 70 4.
87. Eming SA, Smola-Hess S, Kurschat P, Hirche D, Kreig T, Smola H. A novel property pf povidon-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J Invest Dermatol 2006 126 : 2731 3.
88. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001 88 : 4 21.
89. Jones V. Use of hydrogels and iodine in diabetic foot ulcers. Diabetes Foot 1999 2 : 47 54.
90. Lawrence JC. A povidone-iodine medicated dressing. J Wound Care 1998 7 : 332 6.
91. Drosou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. Wounds 2003 15 : 149 66.
92. Apelqvist J, Ragnarson Tennvall G. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine and standard treatment. Acta Derm Venereol 1996 76 : 231 5.
93. Vowden P, Cooper RA. An integrated approach to managing wound infection. EWMA position document: management of wound infection. London : MEP Ltd, 2006 : 2 6.
94. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Vilturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003 52 (Suppl 13 7.
95. Rodeheaver G, Bellamy W, Kody M, Spatafora G, Fitton L, Leyden K, Edlich R. Bactericidal activity and toxicity of iodine-containing solutions in wounds. Arch Surg 1982 117 : 181 6.
96. Oberg MS, Lindsey D. Do not put hydrogen peroxide or povidone-iodine into wounds. Am J Dis Child 1987 141 : 27 8.
97. Goldenheim PD. An appraisal of povidone-iodine and wound healing. Postgrad Med J 1993 69 (Suppl S97 105.
98. Gilchrist B. Should iodine be recognised in wound management? J Wound Care 1998 6 : 148 50.
99. Mayer DA, Tsapogas MJ. Povidone-iodine and wound healing: a critical review. Wounds 1993 5 : 14 23.
100. Burks RI. Povidone-iodine solution in wound treatment. Phys Ther 1998 78 : 212 8.
101. Banwell H. What is the evidence for tissue regeneration impairment when using a formulation of PVP-I antiseptic on open wounds? Dermatology 2006 12 (Suppl 66 76.
102. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006 (1) CD005082.
103. Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg 2005 92 : 665 72.